Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | MERTK | Q12866 | 1/20 | 0.33 |
| ▸ | GAS6 | Q14393 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3141095 | 0.99 | KMT2A (0.45) | KMT2ALMNAFLT3TYRO3MERTK | |
| SCHEMBL698650 | 0.97 | KMT2A (0.40) | KMT2ALMNAFLT3TYRO3MERTK | |
| SCHEMBL9645849 | 0.93 | FLT3 (0.35) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL9373101 | 0.92 | FLT3 (0.37) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL2022080 | 0.88 | KMT2A (0.45) | KMT2ALMNANR1I2AHRCA12 | |
| SCHEMBL27717304 | 0.86 | FLT3 (0.36) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL7458930 | 0.86 | KMT2A (0.40) | KMT2ALMNANR1I2AHRCA12 | |
| SCHEMBL11255263 | 0.85 | FLT3 (0.34) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL9428396 | 0.85 | KMT2A (0.42) | KMT2ALMNANR1I2AHR | |
| SCHEMBL7976903 | 0.83 | KMT2A (0.37) | KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112239458-A | Hindered amine light stabilizer intermediate and preparation method of hindered amine light stabilizer | 利安隆(天津)新材料科技有限公司 | 2021-01-19 | — | — | CN | disclosed |
| US-8830811-B2 | Resin composition and optical component | MITSUI CHEMICALS, INC. (JP) | 2014-09-09 | — | — | US | disclosed |
| EP-1878769-B1 | RESIN COMPOSITION AND OPTICAL COMPONENT | MITSUI CHEMICALS INC (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-8354529-B2 | Polyamine derivative and polyol derivative | BASF SE (DE) | 2013-01-15 | — | — | US | disclosed |
| EP-2511274-A2 | Polyamine derivative | BASF SE (DE) | 2012-10-17 | — | — | EP | disclosed |
| EP-2484677-A1 | Polyamine derivative | BASF SE (DE) | 2012-08-08 | — | — | EP | disclosed |
| US-20120053270-A1 | POLYAMINE DERIVATIVE AND POLYOL DERIVATIVE | MITA NARUYOSHI (JP) | 2012-03-01 | — | — | US | disclosed |
| US-8076478-B2 | Stabilizer; photostability, heat resistance, ozone resistance, oxidation resistance, electromagnetic resistance | BASF SE (DE) | 2011-12-13 | — | — | US | disclosed |
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20090310471-A1 | Resin composition and optical component | MITSUI CHEMICALS, INC. (JP) | 2009-12-17 | — | — | US | disclosed |
| EP-0107615-B1 | POLYOLEFINS STABILIZED BY BIS OR TRIS (POLYALKYLPIPERIDINYL-AMINO) 1,3,5-TRIAZINES | CIBA-GEIGY AG (CH) | 1992-10-28 | — | — | EP | disclosed |
| US-5134233-A | Light stabilizers for organic materials | CIBA-GEIGY CORPORATION (US) | 1992-07-28 | — | — | US | disclosed |
| US-5130429-A | Methylation with formaldehyde in a solvent and distillation | CIBA-GEIGY CORPORATION (US) | 1992-07-14 | — | — | US | disclosed |
| EP-0461071-A1 | Piperidine-triazine compounds containing silane groups, for use as stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1991-12-11 | — | — | EP | disclosed |
| EP-0455588-A1 | Piperidine-triazine compounds for use as stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1991-11-06 | — | — | EP | disclosed |
| EP-0319480-A2 | Process for the methylation of triazine compounds containing 2,2,6,6-tetramethylpiperidine groups | CIBA-GEIGY AG (CH) | 1989-06-07 | — | — | EP | disclosed |
| US-4322337-A | PHOTOSTABILITY | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| EP-0014683-B1 | POLYALKYLPIPERIDINE DERIVATIVES OF S-TRIAZINES, THEIR USE AS STABILIZERS FOR POLYMERS AND POLYMER COMPOSITIONS STABILIZED WITH THESE COMPOUNDS | CIBA-GEIGY AG (CH) | 1981-12-23 | — | — | EP | disclosed |
| US-4288593-A | PHOTOSTABILIZERS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1981-09-08 | — | — | US | disclosed |
| EP-0014683-A1 | Polyalkylpiperidine derivatives of s-triazines, their use as stabilizers for polymers and polymer compositions stabilized with these compounds | CIBA-GEIGY AG (CH) | 1980-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | SEM1, WDR5, WDR1 | KMT2A 736/4885LMNA 2153/4885FLT3 2295/4885 |
| US-20120053270-A1 | POLYAMINE DERIVATIVE AND POLYOL DERIVATIVE | H1-0, H1-3, NPM1 | KMT2A 1254/4885LMNA 315/4885FLT3 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.